MedTrace Logo

Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)

NCT01948427 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 203

Last updated 2024-07-01

Study results available
· View outcomes & findings →

Summary

THRIVE is an observational study that will collect information on patients with UCDs. THRIVE will follow enrolled participants for up to 10 years. As an observational study, enrolled patients will not be required to make any additional office visits or take any medicine outside of normal care.

Conditions

  • Urea Cycle Disorder

Sponsors & Collaborators

Principal Investigators

  • MD · Amgen

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-25
Primary Completion
2020-02-24
Completion
2020-02-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01948427 on ClinicalTrials.gov